Polycystins Expression in Astrocytic Gliomas.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Polycystin 1 (PC1) and polycystin 2 (PC2) are TRP channel proteins encoded by PKD1 and PKD2 genes.
• While known for autosomal dominant polycystic kidney disease, polycystins are implicated in solid tumor pathogenesis.
• Expression of PKD1 and PKD2 in human astrocytomas remains largely uncharacterized.

Purpose of the Study:

• To investigate PKD1 and PKD2 gene expression in astrocytic tumors.
• To correlate PC1 and PC2 protein expression with clinicopathological features of astrocytomas.
• To assess the relationship between polycystin expression and tumor grade, patient age, and gender.

Main Methods:

• Examined 70 astrocytoma cases (8 grade II, 12 grade III, 50 grade IV).
• Quantified mRNA levels of PKD1 and PKD2 using qRT-PCR (ΔΔCt method).
• Detected PC1 and PC2 protein expression via immunohistochemistry (H-score system).

Main Results:

• PKD1 and PKD2 mRNA levels, along with PC1 and PC2 proteins, were significantly elevated in astrocytomas compared to normal brain tissue.
• Glioblastomas (grade IV) showed the highest increase in PKD1, PKD2, PC1, and PC2 expression.
• PC1 expression correlated with patient age, and both PC1 and PC2 showed correlations with p53 immunoexpression in specific grades. PKD1 and PKD2 expression negatively correlated with glioma prognosis.

Conclusions:

• Polycystins (PC1 and PC2) are potentially involved in astrocytoma pathogenesis.
• Elevated polycystin expression in astrocytomas, especially glioblastomas, suggests a role in tumor progression.
• Further research is needed to elucidate the precise mechanisms of polycystin involvement in astrocytoma development.